These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. CLINICAL TETANUS. BULLER DH; VAUGHN CC Mil Med; 1963 Sep; 128():867-70. PubMed ID: 14049664 [No Abstract] [Full Text] [Related]
15. [PROBLEMS RELATED TO PREVENTIVE ADMINISTRATION OF ANTI-TETANUS SERUM]. KOREN K; CHYLO E; SOMODI J Bratisl Lek Listy; 1965 Apr; 45():433-5. PubMed ID: 14318521 [No Abstract] [Full Text] [Related]
16. TETANUS PREVENTION. HARA B J Am Podiatry Assoc; 1965 Aug; 55():599-601. PubMed ID: 14342814 [No Abstract] [Full Text] [Related]
17. [THERAPY OF TETANUS WITH THE USE OF HUMAN TETANUS ANTITOXIN IN THE FORM OF GAMMA GLOBULIN (TETANUS HYPERIMMUNE GLOBULIN)]. VOSS R; SCHOEN HR; KOERNER L; LALLEMAND H; GRABOW L Munch Med Wochenschr; 1965 Apr; 107():854-7. PubMed ID: 14306952 [No Abstract] [Full Text] [Related]
18. [RENAL COMPLICATIONS IN THE TREATMENT OF TETANUS WITH HIGH DOSES OF SERUM]. SALZMANN P Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed; 1963 Dec; 66():470-3. PubMed ID: 14109252 [No Abstract] [Full Text] [Related]
19. CURRENT STATUS OF TETANUS CONTROL. IMPORTANCE OF HUMAN TETANUS-IMMUNE GLOBULIN. SKUDDER PA; MCCARROLL JR JAMA; 1964 May; 188():625-7. PubMed ID: 14121281 [No Abstract] [Full Text] [Related]